Eurax
crotamiton · Cream · Topical
Uses
For eradication of scabies ( Sarcoptes scabiei ) and for symptomatic treatment of pruritic skin.
Dosage and administration
In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Change clothing and bed linen the next morning. Take a cleansing bath 48 hours after the last application. In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as needed. DIRECTIONS FOR PATIENTS WITH SCABIES: Take a routine bath or shower. Thoroughly massage Eurax cream into the skin from the chin to the toes including folds and creases. Put Eurax cream under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax cream under the fingernails. Immediately after use, wrap the toothbrush in paper and throw it away. Use of the same brush in the mouth could lead to poisoning. A second application is advisable 24 hours later. A 60 gram tube is sufficient for two applications. Change clothing and bed linen the next day. Dry clean contaminated clothing and bed linen, or wash in the hot cycle of the washing machine. Take a cleansing bath 48 hours after the last application.
Contraindications
Do not apply Eurax topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.
Warnings
Discontinue treatment with this product if severe irritation or sensitization develops, and institute appropriate therapy.
Precautions
General Do not apply Eurax in the eyes or mouth because it may cause irritation. Do not apply on acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided. Information for Patients See DIRECTIONS FOR PATIENTS WITH SCABIES. Drug Interactions None known. Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term carcinogenicity studies in animals have not been conducted. Pregnancy Animal reproduction studies have not been conducted with Eurax. It is also not known whether Eurax can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax should be given to a pregnant woman only if clearly needed. Pediatric Use Safety and effectiveness in pediatric patients have not been established. Geriatric Use Clinical studies with Eurax (crotamiton, USP) Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Side effects
Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.
Drug interactions
Drug Interactions None known.
Pregnancy
Pregnancy Animal reproduction studies have not been conducted with Eurax. It is also not known whether Eurax can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax should be given to a pregnant woman only if clearly needed.
Pediatric use
Pediatric Use Safety and effectiveness in pediatric patients have not been established.
Geriatric use
Geriatric Use Clinical studies with Eurax (crotamiton, USP) Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Overdosage
There is no specific information on the effect of overtreatment with repeated topical applications in humans. A death was reported but cause was not confirmed. Accidental oral ingestion may be accompanied by burning sensation in the mouth, irritation of the buccal, esophageal and gastric mucosa, nausea, vomiting, abdominal pain. If accidental ingestion occurs, call your Poison Control Center.
Description
Eurax (crotamiton, USP) is a scabicidal and antipruritic agent available as a cream for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton, USP, in a vanishing-cream base containing: carbomer homopolymer type B, cetyl alcohol, diazolidinyl urea, dimethicone, glyceryl monostearate, laureth-23, magnesium aluminum silicate, benzyl alcohol, petrolatum, propylene glycol, sodium hydroxide, steareth-2, and water. Crotamiton is N-ethyl-N-( o -methylphenyl)-2-butenamide and its structural formula is: Crotamiton, USP is a colorless to slightly yellowish oil, having a faint amine-like odor. It is soluble with alcohol and with methanol. Crotamiton is a mixture of the cis and trans isomers. Its molecular weight is 203.28. structurenew
How supplied
Eurax ® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream and supplied as: 60 g tube NDC 69489-311-60 Store at room temperature, 20˚C - 25˚C (68˚F - 77˚F); Excursions permitted: 15˚C - 30˚C (59˚F - 86˚F) [See USP Controlled Room Temperature]. Keep out of reach of children. To report SUSPECTED ADVERSE REACTIONS, contact Journey Medical Corporation at 1-855-531-1859 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . Manufactured for: Journey Medical Corporation Scottsdale, AZ 85258 www.JMCderm.com EUR-P01-R00 Revised 12/2025 logo
Patient information
Information for Patients See DIRECTIONS FOR PATIENTS WITH SCABIES.
Label text from the FDA structured product label by Journey Medical Corporation (revised Dec 17, 2025). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Crotamiton in 1 product
Eurax NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 69489-311 | Crotamiton 100 mg/g Cream | Journey Medical Corporation | NDA |
Frequently asked questions
What is Eurax used for?
For eradication of scabies ( Sarcoptes scabiei ) and for symptomatic treatment of pruritic skin.
What are the side effects of Eurax?
Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients. See the full label for the complete list.
Who makes Eurax?
Eurax is listed by 1 labeler in the FDA NDC directory, including Journey Medical Corporation.